Danielle Schlosser

Danielle Schlosser PhD is the Senior VP of Clinical Innovation at COMPASS Pathways, a mental health company dedicated to accelerating patient access to evidence-based innovation in mental health, including psychedelic therapies. In prior roles, she was responsible for developing the vision and overall strategy for the Behavioral Health portfolio at Verily Life Sciences, an Alphabet company. Prior to joining Verily, she was an Assistant Professor of Psychiatry at the University of California, San Francisco Weill Institute for Neurosciences and the Director of an NIMH-funded translational neuroscience lab, where her lab developed digital therapeutics for individuals with serious mental illness.